Veracyte Inc (VCYT)

HEALTH CARE: HEALTH CARE SERVICES
SIC: SERVICES-MEDICAL LABORATORIES

6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO, CA 94080

Veracyte, Inc. develops molecular tests for oncology. The Company offers molecular cytology and tests for the diagnostic accuracy of cytology samples. Veracyte provides its products and services to healthcare and molecular diagnostic companies in the United States.

Data as of 2021-05-08 11:25:20 -0400
Market Cap2.982 Billion Shares Outstanding67.239 Million Avg 30-day Volume616.922 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-144.4 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.84679 52-week High/Low86.03 / 22.69 Next Earnings Date2021-05-10 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from VCYT instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 3 2 50.0% 2 (0.12%) 1 (0.06%) 100.0%
Funds Holding: 219 186 17.74% 63 (3.78%) 58 (3.61%) 8.62%
13F shares: 65.46 Million 64.065 Million 2.18% 30.795 Million 31.126 Million -1.06%
% Ownership 53.1894 53.7606 -1.06%
New Positions: 56 38 47.37% 19 15 26.67%
Increased Positions 69 75 -8.0% 20 17 17.65%
Closed Positions 23 14 64.29% 13 7 85.71%
Reduced Positions 71 47 51.06% 20 19 5.26%
Total Calls 103.305 Thousand 20.502 Thousand 403.88% 92.5 Thousand
Total Puts 57.01 Thousand 2 Thousand 2750.5% 35 Thousand
PUT/CALL Ratio 0.55 0.1 450.0% 0.38 280.0%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding VCYT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding VCYT BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

4.4 Thousand total shares from 3 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

EASTHAM KARIN

  • Director
8,800 2021-05-03 4

ALLEY BEVERLY JANE VP, CORPORATE CONTROLLER

  • Officer
6,000 2021-04-01 2

BHANJI MUNA

  • Director
0 2021-03-19 2

KENNEDY GIULIA C CHIEF SCIENTIFIC & MED OFFICER

  • Officer
153,849 2021-03-04 11

ANDERSON BONNIE H CHAIRMAN AND CEO

  • Officer
  • Director
372,845 2021-03-02 18

KENNEDY KEITH COO / CFO

  • Officer
116,858 2021-03-02 8

HO MARK

  • PRINCIPAL ACCOUNTING OFFICER
71,728 2021-03-02 7

ERLINGER III JAMES H

  • EVP, GENERAL COUNSEL
22,500 2021-02-26 3

JONES EVAN/ FA

  • Director
99,653 2021-01-22 4

GORDON KEVIN K

  • Director
0 2021-01-04 3

HANNA JOHN WALTER JR CHIEF COMMERCIAL OFFICER

  • Officer
73,844 2020-12-02 9

COHEN FRED E

  • Director
10,000 2020-10-19 3

HOLSTEIN JENS

  • Director
0 2020-08-01 3

EPSTEIN ROBERT S

  • Director
0 2020-07-13 2

BISHOP JOHN L

  • Director
0 2020-06-08 1

NOVA TINA SUSAN

  • Director
0 2020-06-08 1

HALL CHRISTOPHER M PRESIDENT AND COO

  • Officer
28,258 2019-06-03 0

TREU JESSE I

  • Director
1,234,930 2019-02-28 0

KLEINER PERKINS CAUFIELD & BYERS XII, LLC

KPCB XII FOUNDERS FUND, LLC

KPCB XII ASSOCIATES, LLC

  • 10% Owner
No longer subject to file 2017-03-10 0

BROOKS JULIE EVP, GEN COUNSEL AND SECRETARY

  • Officer
4,162 2017-03-03 0

ATWOOD BRIAN G

  • Director
  • 10% Owner
0 2016-06-20 0

GUYER SHELLY D CHIEF FINANCIAL OFFICER

  • Officer
0 2016-03-01 0

POWELL DUNCAN THOMAS PRINCIPAL ACCOUNTING OFFICER

  • Officer
0 2015-03-02 0

DOMAIN PARTNERS VIII, L.P.

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

SCHOEMAKER KATHLEEN K

VITULLO NICOLE

HALAK BRIAN K

  • Director
  • 10% Owner
2,763,294 2014-09-10 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

EASTHAM KARIN - Director by ira

2021-05-05 16:41:00 -0400 2021-05-03 S 3,527 $48.01 d 9,700 indirect yes 1.2326 1.2326 2 0.0 1

EASTHAM KARIN - Director by ira

2021-05-05 16:41:00 -0400 2021-05-03 S 250 $50.03 d 8,800 indirect yes 1.2326 1.2326 2 0.0 1

EASTHAM KARIN - Director by ira

2021-05-05 16:41:00 -0400 2021-05-03 S 650 $49.00 d 9,050 indirect yes 1.2326 1.2326 2 0.0 1

ALLEY BEVERLY JANE - Officer VP, CORPORATE CONTROLLER

2021-04-05 17:04:02 -0400 2021-04-01 A 6,000 a 6,000 direct

BHANJI MUNA - Director

2021-03-23 16:48:12 -0400 2021-03-19 A 11,541 a 11,541 direct 3.9493 11.7231 -8.9379 17.6886 8 -9.2496 30

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
VERACYTE INC VCYT 2021-05-10 22:15:04 UTC -0.2 0.25 1600000
VERACYTE INC VCYT 2021-05-10 21:45:02 UTC -0.2 0.25 1600000
VERACYTE INC VCYT 2021-05-10 21:15:02 UTC -0.2 0.25 1600000
VERACYTE INC VCYT 2021-05-10 20:45:03 UTC -0.2 0.25 1600000
VERACYTE INC VCYT 2021-05-10 20:15:03 UTC -0.2 0.25 1600000
VERACYTE INC VCYT 2021-05-10 19:45:03 UTC -0.2 0.25 1600000
VERACYTE INC VCYT 2021-05-10 19:15:03 UTC -0.2 0.25 1600000
VERACYTE INC VCYT 2021-05-10 18:45:03 UTC -0.2009 0.2509 1600000
VERACYTE INC VCYT 2021-05-10 18:15:03 UTC -0.2009 0.2509 1600000
VERACYTE INC VCYT 2021-05-10 17:45:02 UTC -0.2009 0.2509 1600000
VERACYTE INC VCYT 2021-05-10 17:15:03 UTC -0.2009 0.2509 1600000
VERACYTE INC VCYT 2021-05-10 16:45:03 UTC -0.2009 0.2509 1600000
VERACYTE INC VCYT 2021-05-10 16:15:03 UTC -0.2009 0.2509 1600000
VERACYTE INC VCYT 2021-05-10 15:45:03 UTC -0.2009 0.2509 1600000
VERACYTE INC VCYT 2021-05-10 15:15:03 UTC -0.2009 0.2509 1600000
VERACYTE INC VCYT 2021-05-10 14:45:04 UTC -0.2 0.25 1600000
VERACYTE INC VCYT 2021-05-10 14:15:04 UTC -0.2 0.25 1600000
VERACYTE INC VCYT 2021-05-10 13:45:04 UTC -0.2 0.25 1600000
VERACYTE INC VCYT 2021-05-10 13:15:03 UTC -0.2 0.25 1600000
VERACYTE INC VCYT 2021-05-10 12:45:02 UTC -0.2 0.25 1600000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
RUSSELL INVESTMENT CO- U.S. Small Cap Equity Fund VCYT -14438.0 shares, $-500421.08 2020-10-31 N-PORT
RUSSELL INVESTMENT FUNDS- U.S. Small Cap Equity Fund VCYT -2247.0 shares, $-109968.18 2020-12-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund VCYT -27.0 shares, $-656.37 2020-03-31 N-PORT
RUSSELL INVESTMENT CO- Sustainable Equity Fund VCYT -3201.0 shares, $-181496.7 2021-01-31 N-PORT
RUSSELL INVESTMENT CO- U.S. Dynamic Equity Fund VCYT -4094.0 shares, $-232129.8 2021-01-31 N-PORT

Elevate your investments